Created at Source Raw Value Validated value
June 25, 2024, noon usa

* patients who had received any immuno-modulator therapy * active or chronic kidney/ liver diseases, * oncological diseases * other viral infection including hiv and hepatitis. * any allergic reaction or sensitivity to hep-1 * breast feeding or pregnancy

* patients who had received any immuno-modulator therapy * active or chronic kidney/ liver diseases, * oncological diseases * other viral infection including hiv and hepatitis. * any allergic reaction or sensitivity to hep-1 * breast feeding or pregnancy

Nov. 14, 2020, 11:31 p.m. usa

- patients who had received any immuno-modulator therapy - active or chronic kidney/ liver diseases, - oncological diseases - other viral infection including hiv and hepatitis. - any allergic reaction or sensitivity to hep-1 - breast feeding or pregnancy

- patients who had received any immuno-modulator therapy - active or chronic kidney/ liver diseases, - oncological diseases - other viral infection including hiv and hepatitis. - any allergic reaction or sensitivity to hep-1 - breast feeding or pregnancy